A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Clinical trial NCT06644781 · RECRUITING

Trial details

NCT number: NCT06644781
Sponsor: Daiichi Sankyo
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2025-03-27
Primary completion: 2028-06-01
Enrollment: 510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.